BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22609619)

  • 21. Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.
    Koch G; Brusa L; Carrillo F; Lo Gerfo E; Torriero S; Oliveri M; Mir P; Caltagirone C; Stanzione P
    Neurology; 2009 Jul; 73(2):113-9. PubMed ID: 19597133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Motor complications in patients with Parkinson disease treated with levodopa].
    Luquin MR; Obeso JA; Martínez-Lage JM
    Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dyskinetic patients show rebound worsening of affect after an acute L-dopa challenge.
    Evans AH; Farrell MJ; Gibson SJ; Helme RD; Lim SY
    Parkinsonism Relat Disord; 2012 Jun; 18(5):514-9. PubMed ID: 22366274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological synaptic plasticity in the striatum: implications for Parkinson's disease.
    Picconi B; Pisani A; Barone I; Bonsi P; Centonze D; Bernardi G; Calabresi P
    Neurotoxicology; 2005 Oct; 26(5):779-83. PubMed ID: 15927256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of excitability in human primary somatosensory and motor cortex by paired associative stimulation targeting the primary somatosensory cortex.
    Kriváneková L; Lu MK; Bliem B; Ziemann U
    Eur J Neurosci; 2011 Oct; 34(8):1292-300. PubMed ID: 21978102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptic dysfunction in Parkinson's disease.
    Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
    Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
    Vacherot F; Attarian S; Eusebio A; Azulay JP
    Neurophysiol Clin; 2010 Aug; 40(4):201-8. PubMed ID: 20674816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
    Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
    Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporary occlusion of associative motor cortical plasticity by prior dynamic motor training.
    Stefan K; Wycislo M; Gentner R; Schramm A; Naumann M; Reiners K; Classen J
    Cereb Cortex; 2006 Mar; 16(3):376-85. PubMed ID: 15930370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term and long-term plasticity interaction in human primary motor cortex.
    Iezzi E; Suppa A; Conte A; Li Voti P; Bologna M; Berardelli A
    Eur J Neurosci; 2011 May; 33(10):1908-15. PubMed ID: 21488986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal cortical and brain stem plasticity in Gilles de la Tourette syndrome.
    Suppa A; Belvisi D; Bologna M; Marsili L; Berardelli I; Moretti G; Pasquini M; Fabbrini G; Berardelli A
    Mov Disord; 2011 Aug; 26(9):1703-10. PubMed ID: 21442662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. History of exposure to dopaminergic medication does not affect motor cortex plasticity and excitability in Parkinson's disease.
    Kačar A; Filipović SR; Kresojević N; Milanović SD; Ljubisavljević M; Kostić VS; Rothwell JC
    Clin Neurophysiol; 2013 Apr; 124(4):697-707. PubMed ID: 23085389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I.
    Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN
    Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans.
    Koch G; Mori F; Codecà C; Kusayanagi H; Monteleone F; Buttari F; Fiore S; Bernardi G; Centonze D
    Brain Stimul; 2009 Oct; 2(4):229-33. PubMed ID: 20633421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of dyskinesias in Parkinson's disease.
    Mouradian MM; Heuser IJ; Baronti F; Fabbrini G; Juncos JL; Chase TN
    Ann Neurol; 1989 May; 25(5):523-6. PubMed ID: 2774496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inducing homeostatic-like plasticity in human motor cortex through converging corticocortical inputs.
    Pötter-Nerger M; Fischer S; Mastroeni C; Groppa S; Deuschl G; Volkmann J; Quartarone A; Münchau A; Siebner HR
    J Neurophysiol; 2009 Dec; 102(6):3180-90. PubMed ID: 19726723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.